Drug Profile
PGN 650 I-124
Alternative Names: 124I-PGN 650; PGN 650; PGN-650-124-I; PGN-650-I124Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Affitech A/S; University of Texas M. D. Anderson Cancer Center; University of Texas Southwestern Medical Center
- Developer Avid Bioservices
- Class Diagnostic agents; Imaging agents; Monoclonal antibody diagnostics
- Mechanism of Action Radionuclide imaging enhancers; Tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours